A new study has demonstrated that few breast cancer patients who used common antiinflammatory drugs like aspirin or ibuprofen have drastically lower breast cancer recurrence rates.
The research conducted at the University of Texas Health Science Center at San Antonio and the University of Texas at Austin showed placed the serum in a culture of fat cells that make estrogen, and then placed the serum on breast cancer cells. The serum from overweight and obese patients caused the cancer cells to grow much more aggressively than the serum from patients who were not overweight.
Cancer researcher Linda deGraffenried, Ph.D., from The University of Texas at Austin,said that overweight or obese women diagnosed with breast cancer were facing a worse prognosis than normal-weight women.
Anti-inflammatory use reduced the recurrence rate of ERa positive breast cancer by 50 percent and extended patients' disease-free period by more than two years. ER positive breast cancers, cancers that grew in response to exposure to the hormone estrogen, are among the most common form of the disease, accounting for approximately 75 percent of diagnoses.
The study is published in the journal Cancer Research.
